Late-onset and nonlate-onset schizophrenia: A comparison of clinical characteristics in a multicenter study.
elderly
late-onset
oldage
schizophrenia
Journal
International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
19
01
2021
accepted:
31
01
2021
pubmed:
14
2
2021
medline:
10
8
2021
entrez:
13
2
2021
Statut:
ppublish
Résumé
Data are scarce regarding the potential clinical differences between non-late onset schizophrenia (NLOS, i.e., disorder occurring before 40 years of age), late-onset schizophrenia (LOS, occurring between ages 40 and 60 years) and very-late-onset schizophrenia-like psychosis (VLOSLP, occurring after 60 years of age). Furthermore, previous research compared LOS patients with non-age matched NLOS patients. In this study, we sought to examine potential clinical differences between patients of similar age with LOS and NLOS. This is a cross-sectional multicentre study that recruited in- and outpatients older adults (aged ≥55 years) with an ICD-10 diagnosis of schizophrenia or schizoaffective disorder with NLOS and LOS. Sociodemographic and clinical characteristics, comorbidity, psychotropic medications, quality of life, functioning, and mental health care utilization were drawn for comparison. Two hundred seventy-two participants (79.8%) had NLOS, 61 (17.9%) LOS, and 8 (2.3%) VLOSLP. LOS was significantly and independently associated with greater severity of emotional withdrawal and lower severity of depression (all p < 0.05). However, the magnitude of these associations was modest, with significant adjusted odds ratios ranging from 0.71 to 1.24, and there were no significant between-group differences in other characteristics. In an age-matched multicenter sample of elderly patients with schizophrenia, older adults with LOS were largely similar to older adults with NLOS in terms of clinical characteristics. The few differences observed may be at least partially related to symptom fluctuation with time. Implications of these findings for pharmacological and nonpharmacological management is yet to be determined.
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1204-1215Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Cohen CI, Meesters PD, Zhao J. New perspectives on schizophrenia in later life: implications for treatment, policy, and research. Lancet Psychiatry. 2015;2(4):340-350. https://doi.org/10.1016/S2215-0366(15)00003-6.
Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet Lond Engl. 2013;382(9904):1575-1586. https://doi.org/10.1016/S0140-6736(13)61611-6.
Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI. Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am J Geriatr Psychiatry. 2003;11(6):648-657.
Hoertel N, Limosin F, Leleu H. Poor longitudinal continuity of care is associated with an increased mortality rate among patients with mental disorders: results from the French National Health Insurance Reimbursement Database. Eur Psychiatry J Assoc Eur Psychiatr. 2014;29(6):358-364. https://doi.org/10.1016/j.eurpsy.2013.12.001.
Jeste D, Lanouette N, Vahia I. Schizophrenia and paranoid disorders. In: Blazer DG, Steff ens DC, eds. Textbook of Geriatric Psychiatry. 4th ed. Washington, DC: American Psychiatric Press; 2009:317-331.
Howard R, Rabins PV, Seeman MV, Jeste DV. Late-onset the I. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatr. 2000;157(2):172-178. https://doi.org/10.1176/appi.ajp.157.2.172.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. American Psychiatric Association; 2013.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems; 2016.
Chen L, Selvendra A, Stewart A, Castle D. Risk factors in early and late onset schizophrenia. Compr Psychiatr. 2018;80:155-162. https://doi.org/10.1016/j.comppsych.2017.09.009.
Convert H, Védie C, Paulin P. [Late-onset schizophrenia or chronic delusion]. L'Encephale. 2006;32(6 Pt 1):957-961.
Vahia IV, Palmer BW, Depp C, et al. Is late-onset schizophrenia a subtype of schizophrenia?: late-onset schizophrenia. Acta Psychiatr Scand. 2010;122(5):414-426. https://doi.org/10.1111/j.1600-0447.2010.01552.x.
Maglione JE, Thomas SE, Jeste DV. Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia?. Curr Opin Psychiatr. 2014;27(3):173-178. https://doi.org/10.1097/YCO.0000000000000049.
Suen YN, Wong SMY, Hui CLM, et al. Late-onset psychosis and very-late-onset-schizophrenia-like-psychosis: an updated systematic review. Int Rev Psychiatry Abingdon Engl. Published online October. 2019;10:1-20. https://doi.org/10.1080/09540261.2019.1670624.
Van Assche L, Morrens M, Luyten P, Van de Ven L, Vandenbulcke M. The neuropsychology and neurobiology of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: a critical review. Neurosci Biobehav Rev. 2017;83:604-621. https://doi.org/10.1016/j.neubiorev.2017.08.024.
Brichant-Petitjean C, Legauffre C, Ramoz N, Ades J, Gorwood P, Dubertret C. Memory deficits in late-onset schizophrenia. Schizophr Res. 2013;151(1-3):85-90. https://doi.org/10.1016/j.schres.2013.08.021.
Hanssen M, van der Werf M, Verkaaik M, et al. Comparative study of clinical and neuropsychological characteristics between early-, late and very-late-onset schizophrenia-spectrum disorders. Am J Geriatr Psychiatr. 2015;23(8):852-862. https://doi.org/10.1016/j.jagp.2014.10.007.
Talaslahti T, Alanen H-M, Hakko H, Isohanni M, Häkkinen U, Leinonen E. Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia. Int J Geriatr Psychiatr. 2015;30(5):453-459. https://doi.org/10.1002/gps.4159.
Sachdev P, Brodaty H. Quantitative study of signal hyperintensities on T2-weighted magnetic resonance imaging in late-onset schizophrenia. Am J Psychiatr. 1999;156(12):1958-1967. https://doi.org/10.1176/ajp.156.12.1958.
Palmer BW, Bondi MW, Twamley EW, Thal L, Golshan S, Jeste DV. Are late-onset schizophrenia spectrum disorders neurodegenerative conditions?: annual rates of change on two dementia measures. J Neuropsychiatry Clin Neurosci. 2003;15(1):45-52. https://doi.org/10.1176/jnp.15.1.45.
Brodaty H, Sachdev P, Koschera A, Monk D, Cullen B. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br J Psychiatry J Ment Sci. 2003;183:213-219. https://doi.org/10.1192/bjp.183.3.213.
Lagodka A, Robert P. La schizophrénie tardive est-elle secondaire à des processus neurodégénératifs? Une revue de la littérature. L'Encéphale. 2009;35(4):386-393. https://doi.org/10.1016/j.encep.2008.06.008.
Yasuda M, Kobayashi T, Kato S, Kishi K. Clinical features of late-onset schizophrenia in Japan: comparison with early-onset cases: late-onset schizophrenia in Japan. Psychogeriatrics. 2013;13(4):244-249. https://doi.org/10.1111/psyg.12032.
Ramasamy S, Bharath S. Clinical characteristics of patients with non-affective, non-organic, late onset psychosis. Asian J Psychiatry. 2017;25:74-78. https://doi.org/10.1016/j.ajp.2016.10.017.
McGlashan TH, Johannessen JO. Early detection and intervention with schizophrenia: rationale. Schizophr Bull. 1996;22(2):201-222. https://doi.org/10.1093/schbul/22.2.201.
Hoertel N, Jaffré C, Pascal de Raykeer R, et al. Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: prevalence and associated factors in a multicenter study. J Affect Disord. 2019;251:60-70. https://doi.org/10.1016/j.jad.2019.03.007.
Abou Kassm S, Hoertel N, Naja W, et al. Metabolic syndrome among older adults with schizophrenia spectrum disorder: prevalence and associated factors in a multicenter study. Psychiatr Res 2019;275:238-246. https://doi.org/10.1016/j.psychres.2019.03.036.
Morlet E, Costemale-Lacoste J-F, Poulet E, et al. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: a cross-sectional multicenter study. J Affect Disord. 2019;259:210-217. https://doi.org/10.1016/j.jad.2019.08.056.
Schuster J-P, Hoertel N, von Gunten A, Seigneurie A-S, Limosin F, CSA Study group. Benzodiazepine use among older adults with schizophrenia spectrum disorder: prevalence and associated factors in a multicenter study. Int Psychogeriatr. 2019:32(4):441-451. Published online May 7. https://doi.org/10.1017/S1041610219000358.
Pascal de Raykeer R, Hoertel N, Blanco C, et al. Effects of depression and cognitive impairment on quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study. J Affect Disord. 2019;256:164-175. https://doi.org/10.1016/j.jad.2019.05.063.
Hoertel N, Rotenberg L, Blanco C, et al. Psychiatric symptoms and quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study. Eur Arch Psychiatr Clin Neurosci. 2019. Published online May 27. 270(6):673-688. https://doi.org/10.1007/s00406-019-01026-9.
Hoertel N, Rotenberg L, Blanco C, et al. A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study. Soc Psychiatr Psychiatr Epidemiol. 2020. Published online May 15. https://doi.org/10.1007/s00127-020-01880-2.
Raucher-Chéné D, Hoertel N, Béra-Potelle C, et al. Mental healthcare in older adults with schizophrenia: results from 118 French public psychiatric departments. Int Psychogeriatr. 2015;27(10):1749-1750. https://doi.org/10.1017/S1041610215001064.
Hébert R, Dubois MF, Wolfson C, Chambers L, Cohen C. Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci. 2001;56(11):M693-M699.
Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association. Am J Psychiatr. 1997;154(4 Suppl):1-63.
Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatr. 2003;64(6):663-667.
Ewing JA. Detecting alcoholism. The CAGE questionnaire. J Am Med Assoc. 1984;252(14):1905-1907.
Kitchens JM. Does this patient have an alcohol problem?. J Am Med Assoc. 1994;272(22):1782-1787.
Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised; 1976. Published online.
Overall JE, Gorham DR. The Brief psychiatric rating scale. Psychol Rep. 1962;10:799-812. http://dx.doi.org/10.2466/pr0.1962.10.3.799.
Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief psychiatric rating scale scores. Br J Psychiatry J Ment Sci. 2005;187:366-371. https://doi.org/10.1192/bjp.187.4.366.
Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10(3):388-398.
Lehman AF. Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatr Psychiatr Epidemiol. 1996;31(2):78-88.
Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatr. 1976;33(6):766-771.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
Midi H, Sarkar SK, Rana S. Collinearity diagnostics of binary logistic regression model. J Interdiscipl Math. 2010;13(3):253-267. https://doi.org/10.1080/09720502.2010.10700699.
Schafer JL. Analysis of Incomplete Multivariate Data. London: Chapman and Hall; 1997.
Sato T, Bottlender R, Schröter A, Möller H-J. Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments. Schizophr Res. 2004;67(2-3):175-183. https://doi.org/10.1016/S0920-9964(03)00015-X.
Khan IA, Araujo M, Cohen C. What happens to negative symptoms in schizophrenia in later life and what can be done about them? Int J Geriatr Psychiatr. 2012;20:S93-S94.
Oorschot M, Lataster T, Thewissen V, et al. Emotional experience in negative symptoms of schizophrenia--no evidence for a generalized hedonic deficit. Schizophr Bull. 2013;39(1):217-225. https://doi.org/10.1093/schbul/sbr137.
Cohen CI, Ryu HH. A longitudinal study of the outcome and associated factors of subsyndromal and syndromal depression in community-dwelling older adults with schizophrenia spectrum disorder. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2015;23(9):925-933. https://doi.org/10.1016/j.jagp.2014.06.011.
Frank Harrell, Slaughter J. Biostatistics for biomedical research. Published online November 11, 2020. Accessed January 9, 2021. https://hbiostat.org/doc/bbr.pdf.